How to use analogies for breakthrough innovations

Analogies can trigger breakthrough ideas in new product development. Numerous examples demonstrate that substantial innovations often result from transferring problem solutions from one industry or domain to another. For instance, the designers of the new running shoe generation of Nike, Nike SHOX, use the same suspension concept like the technologies applied for Formula 1 racing cars, or the biological Lotus-effect led to the development of various self-cleaning surfaces. Academic research on analogical thinking has been so far heavily influenced by general theoretical work from cognitive psychology or systematic inventing. Only a small number of studies have investigated the application of analogies in the specific context of breakthrough innovation projects. This paper focuses on the question how analogies can be systematically used in the early innovation phases of new product development and which factors influence the successful use of analogical thinking in innovating companies. Special attention is paid to organizational facilitators and the requests on people involved in this process. --

Removing black-hole singularities with nonlinear electrodynamics

We propose a way to remove black hole singularities by using a particular nonlinear electrodynamics Lagrangian that has been recently used in various astrophysics and cosmological frameworks. In particular, we adapt the cosmological analysis discussed in a previous work to the black hole physics. Such analysis will be improved by applying the Oppenheimer-Volkoff equation to the black hole case. At the end, fixed the radius of the star, the final density depends only on the introduced quintessential density term $\rho_{\gamma}$ and on the mass.Comment: In this last updated version we correct two typos which were present in Eqs. (21) and (22) in the version of this letter which has been published in Mod. Phys. Lett. A 25, 2423-2429 (2010). In the present version, both of Eqs. (21) and (22) are dimensionally and analytically correc

Pd–In intermetallic nanoparticles with high catalytic selectivity for liquid-phase semi-hydrogenation of diphenylacetylene

Intermetallic nanoparticles (NPs) are highly interesting materials in catalysis due to their geometrically ordered structures and altered electronic properties, but the synthesis of defined intermetallic NPs remains a challenge. Here, we report a novel and facile approach for the synthesis of intermetallic Pd–In NPs in ionic liquids (ILs) at moderate temperatures. Depending on the molar ratio of the metal precursors and the reaction temperature, single-phase Pd$_3$In, PdIn and Pd$_3$In$_7$ NPs were obtained, which was confirmed, e.g. by powder X-ray diffraction, electron microscopy, and optical emission spectroscopy with inductively coupled plasma. The Pd–In NPs stabilized in ILs were used as catalysts in the liquid-phase semi-hydrogenation of diphenylacetylene (DPA). Highly ordered PdIn NPs with a CsCl type structure revealed both high activity and selectivity to cis-stilbene even at full DPA conversion. Intermetallic compounds such as PdIn can be used to isolate contiguous Pd atoms with another base metal into single Pd sites, thereby increasing the catalytic selectivity of Pd while stabilizing the individual sites in the intermetallic structures. This work may provide new pathways for the synthesis of single-phase intermetallic NPs and future insights into a more rational design of bimetallic catalysts with specific catalytic properties

Characterization and sorption properties of low pH cements

Characterization of three low pH cement pastes, including the description of their sorption properties for tritiated water (HTO), 36Cl- and 129I- is described in this work. SEM-EDX and NMR analyses show that after 90 days of hydration, the main hydrated phases are C-S-H and C-A-S-H gels with a Ca:Si ratio between 0.8 - 1.0 and a Al:Si ratio of 0.05. TG-DSC and XRD indicate the presence of calcite in the mixtures where limestone filler has been used. Additional techniques were used to identify minor hydrated solid phases like ettringite (i.e., XRD and solid state NMR). Porosity and pore size distribution was characterized by MIP observing that the size of the pores in the hydrated cement phases varies from the micro to the nanoscale. Uptake studies of HTO, 36Cl- and 129Ifrom batch sorption experiments indicate very weak sorption (Kd < 0.40 ± 0.13 L/kg) for the 3 selected radionuclides. The uptake process of 36Cl- and 129I- is probably associated with surface processes in the C-S-H and C-A-S-H phases with competition for sorption sites, between them. In the case of HTO, isotopic exchange with the interlayer water of the C-S-H and the C-A-S-H seems to be the main uptake process

Soluble Triggering Receptor Expressed on Myeloid Cells 1 Is Released in Patients with Stable Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is increasingly recognized as a systemic disease that is associated with increased serum levels of markers of systemic inflammation. The triggering receptor expressed on myeloid cells 1 (TREM-1) is a recently identified activating receptor on neutrophils, monocytes, and macrophage subsets. TREM-1 expression is upregulated by microbial products such as the toll-like receptor ligand lipoteichoic acid of Gram-positive or lipopolysaccharides of Gram-negative bacteria. In the present study, sera from 12 COPD patients (GOLD stages I–IV, FEV1 51 ± 6%) and 10 healthy individuals were retrospectively analyzed for soluble TREM-1 (sTREM-1) using a newly developed ELISA. In healthy subjects, sTREM-1 levels were low (median 0.25 ng/mL, range 0–5.9 ng/mL). In contrast, levels of sTREM-1 in sera of COPD patients were significantly increased (median 11.68 ng/mL, range 6.2–41.9 ng/mL, P<.05). Furthermore, serum levels of sTREM-1 showed a significant negative correlation with lung function impairment. In summary, serum concentrations of sTREM-1 are increased in patients with COPD. Prospective studies are warranted to evaluate the relevance of sTREM-1 as a potential marker of the disease in patients with COPD